Thank you, Mr. Chair.
I want to reassure my colleagues: we are here to answer their questions. The Standing Committee on Science and Research is probably one of the most important House of Commons committees. I want to thank each of its members for sitting on the committee.
Before starting my remarks, I would like to repeat what a scientist recently told me: today's science is tomorrow's economy.
I am pleased to be appearing for the first time before this committee, which is an essential one, given the importance of science, and especially of research, for Canada's future and prosperity.
As a member of a government that places great importance on science and on making evidence-based decisions, I am grateful for this committee's excellent work. I would also note that I supported creating this committee during the last session of Parliament.
Today, I am here to discuss two subjects of interest to members of the committee: research and scientific publication in French, an issue that interests me since I come from the Canadian education system in French myself, and international moonshot programs.
Our government has worked hard to support a robust science and research base in Canada and to ensure that we are prosperous and, certainly, that we are competitive. As is the case for all government policies and programs, the initiatives are based on the values of equity, diversity and inclusion.
Just as diversity is a major asset for Canadian research, our linguistic duality is our hallmark and adds to the diversity of ideas, connections and collaborations in Canada and on the international scene. We can all agree on that. As a former minister of foreign affairs, I can say that the fact that our country has two official languages is an essential asset in the economy of the 21st century.
Our linguistic duality also makes us a premier destination for French-speaking researchers worldwide, and that is a good thing. That is why we fund research and research training in either language and we encourage education in French, which is vital and very important to me, as we all know.
For example, grants to assist academic journals have been established to help in exploring innovative ideas and to cover the costs associated with publishing scientific articles. Numerous publications supported by these grants are in French or support the publication of research in French.
There are also science communication skills development grants that support organizations offering communications training for students, scholarship holders and professors in the fields of science, technology, engineering and mathematics.
The Natural Sciences and Engineering Research Council of Canada conducts two annual campaigns to promote the sciences: Science Odyssey and Science Literacy Week, both of which actively involve francophones and promote French-language content.
I am always ready to hear about new ideas and international best practices that allow for greater equity in the funding and distribution of research in French. I give you my word that we will continue doing our best to accomplish this.
That brings me to the other topic of interest at this committee, moon shot research. You kind of know me by now. I've been ambitious, and I want Canada to have the same level of ambition.
It is vital that we focus our attention not only on the immediate matters we are facing as a nation but also on the long-term challenges and opportunities we face as a society, and I would say, indeed, globally. I want Canada to lead. That's always where I put us when it comes to science, technology and innovation.
Never before in our lifetimes has the importance of science-led decision-making been so starkly apparent as during the COVID-19 pandemic. I would say, in a way, that Canadians have reconnected with science. Certainly, we all owe a debt of gratitude to the exceptional scientists across Canada and, I would say, the world, who have worked tirelessly to help us combat the virus.
To make sure that we are even better prepared for future health emergencies, the Government of Canada is making strategic investments in cutting edge life sciences and biotechnology research.
Colleagues, you will allow me to express with great pride that we have Moderna now, which has invested significantly in our country. When I started as minister, our fill and finish capacity on the vaccines was around 30 million doses. I think today it's fair to say that we're above 600 million doses.
We also have to make sure that we can accelerate the development and commercialization of world-class Canadian research on vaccines and treatments. We must also make sure that we have the essential research talent to build a more robust biomanufacturing ecosystem.
This is why the government launched the biomanufacturing and life sciences strategy, to ensure that Canada has the skills, the experience and the expertise to develop vaccines and therapeutics as a global leader in the life sciences field. The strategy is already showing success through our nearly $2-billion investment. We're seeing global vaccine producers coming to Canada.
Vaccines are just one. The government is generating big and bold ideas, as you've seen, whether it's quantum AI or cybersecurity, which I think are going to be key to the underpinning growth in our national economy.
Mr. Chair, I would have more to say, but I see that you are impatient and that colleagues are impatient to ask me questions.
I'm very pleased to be here.
Thank you for inviting me here today, ladies and gentlemen.